Barbara Plecko

ORCID: 0000-0002-3203-1325
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metabolism and Genetic Disorders
  • Mitochondrial Function and Pathology
  • Biochemical and Molecular Research
  • Folate and B Vitamins Research
  • Lysosomal Storage Disorders Research
  • Amino Acid Enzymes and Metabolism
  • Genetics and Neurodevelopmental Disorders
  • Genomics and Rare Diseases
  • Neonatal Health and Biochemistry
  • RNA regulation and disease
  • RNA modifications and cancer
  • Diet and metabolism studies
  • Epilepsy research and treatment
  • Neurogenetic and Muscular Disorders Research
  • Glycogen Storage Diseases and Myoclonus
  • Autoimmune Neurological Disorders and Treatments
  • Genetic Neurodegenerative Diseases
  • Child and Adolescent Health
  • Childhood Cancer Survivors' Quality of Life
  • Alcoholism and Thiamine Deficiency
  • Infectious Encephalopathies and Encephalitis
  • Genomic variations and chromosomal abnormalities
  • Neurological and metabolic disorders
  • Congenital Anomalies and Fetal Surgery
  • Carbohydrate Chemistry and Synthesis

Medical University of Graz
2012-2025

SMART Reading
2024

University Children's Hospital Zurich
2013-2022

University of Zurich
2012-2022

Universitätsklinik für Kinder und Jugendpsychiatrie
2004-2022

Graz University Hospital
2006-2021

Zentrum für Kinderheilkunde
2005-2021

University of Graz
1993-2021

John Wiley & Sons (United States)
2020

Hudson Institute
2020

The low-density lipoprotein receptor (LDLR) plays a pivotal role in clearing atherogenic circulating (LDL) cholesterol. Here we show that the COMMD/CCDC22/CCDC93 (CCC) and Wiskott-Aldrich syndrome protein SCAR homologue (WASH) complexes are both crucial for endosomal sorting of LDLR its function. We find patients with X-linked intellectual disability caused by mutations CCDC22 hypercholesterolaemic, COMMD1-deficient dogs liver-specific Commd1 knockout mice have elevated plasma LDL...

10.1038/ncomms10961 article EN cc-by Nature Communications 2016-03-11
Michael Zech Robert Jech Sylvia Boesch Matěj Škorvánek Sandrina Weber and 95 more Matias Wagner Chen Zhao Angela Jochim Ján Necpál Yasemin Dincer Katharina Vill Felix Distelmaier Malgorzata Stoklosa Martin Krenn Stephan Grunwald Tobias Bock-Bierbaum Anna Fečíková Petra Havránková Jan Roth Iva Příhodová Miriam Adamovičová Olga Ulmanová Karel Bechyně Pavlína Danhofer Branislav Veselý Vladimír Haň Petra Pavelekova Zuzana Gdovinová Tobias Mantel Tobias Meindl Alexandra Sitzberger Sebastian Schröder Astrid Blaschek Timo Roser Michaela Bonfert Edda Haberlandt Barbara Plecko Birgit Leineweber Steffen Berweck T. Herberhold Berthold Langguth Jana Švantnerová Michal Minár Gonzalo Alonso Ramos-Rivera Monica H. Wojcik Sander Pajusalu Katrin Õunap Ulrich A. Schatz Laura Pölsler Ivan Milenković Franco Laccone Veronika Pilshofer Roberto Colombo Steffi Patzer Arcangela Iuso Julia Vera Mónica Troncoso Fang Fang Holger Prokisch Friederike Wilbert Matthias Eckenweiler Elisabeth Graf Dominik S. Westphal Korbinian M. Riedhammer Theresa Brunet Bader Alhaddad Riccardo Berutti Tim M. Strom Martin Hecht Matthias Baumann Marc E. Wolf Aida Telegrafi Richard Person Francisca Millan Zamora Lindsay B. Henderson David Weise Thomas Musacchio Jens Volkmann Anna Szuto Jessica Becker Kirsten Cremer Thomas Sycha Fritz Zimprich Verena Kraus Christine Makowski Pedro Gonzalez‐Alegre Tanya Bardakjian Laurie J. Ozelius Annalisa Vetro Renzo Guerrini Esther M. Maier Ingo Borggraefe Alice Kuster Saskia B. Wortmann Annette Hackenberg Robert Steinfeld Birgit Assmann Christian Staufner Thomas Opladen Evžen Růžička

10.1016/s1474-4422(20)30312-4 article EN The Lancet Neurology 2020-10-21

Glutaryl-CoA dehydrogenase deficiency (GDD) is a recessively inherited neurometabolic disorder associated with encephalopathic crises and severe extrapyramidal symptoms. Treatment regimens including glucose electrolyte infusions during acute illnesses, oral carnitine supplementation and/or low-protein or lysine-restricted diet have been recommended, but their efficacy has documented only on an anecdotal basis.

10.1055/s-2007-973761 article EN Neuropediatrics 1996-06-01

Severe myoclonic epilepsy of infancy (SMEI or Dravet syndrome) is a rare disorder occurring in young children often without family history similar disorder. The earliest disease manifestations are usually fever-associated seizures. Later life, patients display different types afebrile seizures including Arrest psychomotor development occurs the second year life and most become ataxic. Patients resistant to antiepileptic drug therapy. Recently, we described de novo mutations neuronal sodium...

10.1002/humu.10217 article EN Human Mutation 2003-04-22

Abstract Objective Folinic acid–responsive seizures and pyridoxine‐dependent epilepsy are two treatable causes of neonatal epileptic encephalopathy. The former is diagnosed by characteristic peaks on cerebrospinal fluid (CSF) monoamine metabolite analysis; its genetic basis has remained elusive. latter due to α‐aminoadipic semialdehyde (α‐AASA) dehydrogenase deficiency, associated with pathogenic mutations in the ALDH7A1 ( antiquitin ) gene. We report patients whose CSF showed marker folinic...

10.1002/ana.21568 article EN Annals of Neurology 2009-01-13

<h3>Background</h3> Next generation sequencing has become the core technology for gene discovery in rare inherited disorders. However, interpretation of numerous sequence variants identified remains challenging. We assessed application exome diagnostics complex I deficiency, a disease with vast genetic heterogeneity. <h3>Methods</h3> Ten unrelated individuals deficiency were selected and sequential bioinformatic filtering. Cellular rescue experiments performed to verify pathogenicity novel...

10.1136/jmedgenet-2012-100846 article EN Journal of Medical Genetics 2012-04-01

The first described patients with pyridox(am)ine 5'-phosphate oxidase deficiency all had neonatal onset seizures that did not respond to treatment pyridoxine but responded pyridoxal 5'-phosphate. Our data suggest, however, the clinical spectrum of is much broader than has been reported in literature. Sequencing PNPO gene was undertaken for a cohort 82 individuals who shown reduction frequency and severity response or Novel sequence changes were studied using new cell-free expression system...

10.1093/brain/awu051 article EN cc-by-nc Brain 2014-03-18

Patients with pyridoxine dependent epilepsy (PDE) present early-onset seizures resistant to common anticonvulsants. According the benefit of (vitamin B(6)) and recurrence on withdrawal, patients so far have been classified as having definite, probable, or possible PDE. Recently, PDE has shown be caused by a defect alpha-amino adipic semialdehyde (AASA) dehydrogenase (antiquitin) in cerebral lysine degradation pathway. The accumulating compound piperideine-6-carboxylic acid (P6C) was...

10.1002/humu.20433 article EN Human Mutation 2006-01-01

<h3>Background</h3> <i>NKX2-1</i> encodes a transcription factor with large impact on the development of brain, lung and thyroid. Germline mutations can lead to dysfunction malformations these organs. Starting from largest coherent collection patients suspected phenotype date, we systematically evaluated frequency, quality spectrum phenotypic consequences mutations. <h3>Methods</h3> After identifying by Sanger sequencing array CGH, comprehensively reanalysed affected their relatives. We...

10.1136/jmedgenet-2013-102248 article EN Journal of Medical Genetics 2014-04-08

Objectives The majority of people with suspected genetic dystonia remain undiagnosed after maximal investigation, implying that a number causative genes have not yet been recognized. We aimed to investigate this paucity diagnoses. Methods undertook weighted burden analysis whole‐exome sequencing (WES) data from 138 individuals unresolved generalized etiology, followed by additional case‐finding international databases, first for the gene implicated ( VPS16 ), and then other functionally...

10.1002/ana.25879 article EN cc-by Annals of Neurology 2020-08-28

Abstract Glutaric aciduria type 1 is a rare inherited neurometabolic disorder of lysine metabolism caused by pathogenic gene variations in GCDH (cytogenic location: 19p13.13), resulting deficiency mitochondrial glutaryl‐CoA dehydrogenase (GCDH) and, consequently, accumulation glutaric acid, 3‐hydroxyglutaric glutaconic acid and glutarylcarnitine detectable gas chromatography/mass spectrometry (organic acids) tandem mass (acylcarnitines). Depending on residual activity, biochemical high low...

10.1002/jimd.12566 article EN cc-by-nc-nd Journal of Inherited Metabolic Disease 2022-10-12

Cardio‐facio‐cutaneous (CFC) and Costello syndrome (CS) are congenital disorders with a significant clinical overlap. The recent discovery of heterozygous mutations in genes encoding components the RAS–RAF–MAPK pathway both CFC CS suggested similar underlying pathogenesis these two disorders. While is heterogeneous BRAF , MAP2K1 MAP2K2 KRAS HRAS alterations almost exclusively associated CS. We carried out comprehensive mutation analysis 51 CFC‐affected patients 31 individuals Twelve...

10.1111/j.1399-0004.2007.00931.x article EN Clinical Genetics 2007-11-27

To evaluate the efficacy and safety of dietary lysine restriction as an adjunct to pyridoxine therapy on biochemical parameters, seizure control, developmental/cognitive outcomes in children with pyridoxine-dependent epilepsy (PDE) caused by antiquitin (ATQ) deficiency. In this observational study, seven confirmed ATQ deficiency were started regular nutritional monitoring. Biochemical evaluated using pipecolic acid α-aminoadipic semialdehyde (AASA) levels body fluids; age-appropriate tests...

10.1016/j.ymgme.2012.09.006 article EN cc-by-nc-nd Molecular Genetics and Metabolism 2012-09-10
Coming Soon ...